[Control of the systolic blood pressure and related factors in patients with high cardiovascular risk]

An Med Interna. 2006 Mar;23(3):119-23. doi: 10.4321/s0212-71992006000300005.
[Article in Spanish]

Abstract

Objective: To know in a good therapeutic compliance population with high cardiovascular risk (HCR), the systolic blood pressure (SBP) control-rate and the factors that could influence.

Material and method: A cross-sectional observational study was carried out in a HCR hypertensive population in Cáceres (Spain). A survey of different laboratory tests, SBP in first and last visits.

Results: Among 388 HCR hypertensive patients, 199 (51.4%) patients with antihypertensive treatment adherence was selected. The average age was of 63 +/- 11 years, 109 (54.1%) males, 61 (30.7%) diabetes mellitus (DM) ones, the 10 years global cardiovascular risk was 22.25 +/- 8.9%, average follow-up was 16.5 +/- 8 months, means SBP was 158 +/- 22 mm Hg. 59.5% with combined treatment, generally diurets with another antihypertensive one. SBP less 140 mm Hg was observe in 23.9% and, only 13.5% less than 130 mm Hg in DM patients. SBP control was more common in less than five years hypertension diagnosis (with respect to those of more time evolution (33.8% vs 15.7%: p < 0.01). as well as, in those with beat pressure (BP) less of 60 mmHg (73.3% versus 26.7%; p < 0.0005). In multivariable analysis also influences negatively in the SBP control: upper 5 years hypertension diagnosis, OR 1.92 (1.08-3.4; p < 0.05) and, a greater BP of 60 mmHg, OR 30.3 (10.6-87: p < 0.0001).

Conclusions: SBP control is difficult to obtain in a population of HCR and good therapeutic compliance, but more still in DM patients. A time of more 5 years evolution of the hypertension and, BP upper of 60 mm HG, have a negative influences in the SBP control.

Publication types

  • English Abstract

MeSH terms

  • Aged
  • Antihypertensive Agents / classification
  • Antihypertensive Agents / therapeutic use*
  • Cardiovascular Diseases / epidemiology*
  • Cohort Studies
  • Comorbidity
  • Cross-Sectional Studies
  • Diabetes Complications / epidemiology
  • Female
  • Humans
  • Hyperlipidemias / epidemiology
  • Hypertension / drug therapy*
  • Hypertension / epidemiology
  • Male
  • Middle Aged
  • Prospective Studies
  • Registries
  • Risk Factors
  • Spain / epidemiology
  • Systole* / drug effects
  • Treatment Outcome

Substances

  • Antihypertensive Agents